Purpose/Objective: The aim of this study was the clinical validation of a customized eye tracking system (ETS) for noninvasive tumor localization and automatic motion detection in proton therapy of intraocular tumors. Materials and Methods: A prototypal ETS was tested in clinical proton therapy at Centre Antoine Lacassagne in Nice (FR). The device aims at accurate tumor localization by applying 3D infrared video-oculography technique. The cornea and pupil centers are recognized on the images acquired by two calibrated video cameras, exploiting the eye reflections produced by two infrared light sources. This allows the assessment of the 3D position and orientation of the observed eye. A custom-made calibration chessboard fitted with radiopaque beads was used to calibrate the ETS and the in-room imaging with respect to the treatment room isocenter ( fig. 1 .a). The direct linear transformation (DLT) algorithm was applied to perform geometrical calibration of the orthogonal X-Ray system using multiple radiographic images of the chessboard. Then, the concurrent localization of chessboard corners in ETS images and radiopaque beads in X-ray projections allows the calibration of the eye tracker ( fig. 1.b ). The ETS reliability in tumor localization was tested during the treatment preparation ( fig. 1 .c-d) of three eye cancer patients for proton irradiation. All of them had tantalum markers to localize the target volume. Initial patient setup error was estimated by acquiring orthogonal Xray images. Then, after applying treatment chair corrections, a further acquisition was performed for final setup verification. The markers position in the X-ray verification images were compared with those estimated by the ETS according to the detected eye position and orientation. Absolute 3D markers localization error for the entire patient cohort is shown in table 1. Moreover, when more than two markers were clearly distinguishable in X-ray projections, the imposed chair transformation is estimated and compared with the ETS observed setup correction.
Results:
The mean retro-projection error (± standard deviation) for the DLT calibration of the X-ray system was 0.06±0.03 mm. The 3D error on clips position provided by the ETS was measured below 0.75 mm, (tab. 1). Moreover, rotations and translations of clips between initial and verification X-Ray acquisition, as seen by the ETS and the X-Ray imaging system, are reported.
Conclusions:
The ETS prototype provides high accuracy in target localization and complies with the high standard required in proton therapy of intraocular tumors. Future activities will be focused on inter-fraction data acquisition to test the ETS accuracy and robustness.
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Calculation of interplay effects caused by liver tumor motion during scanning proton therapy P. Poulsen 1 , E. Worm 2 , M. Høyer 1 , C. Grau 1 , J.B.B. Petersen 1 1 Aarhus University Hospital, Department of Oncology, Aarhus C, Denmark 2 Aarhus University Hospital, Department of Medical Physics, Aarhus C, Denmark Purpose/Objective: Intrafraction tumor motion in scanning proton therapy may substantially distort the delivered dose distribution. These interplay effects are in particular a concern for hypofractionated treatments of liver tumors due to the large respiratory motion. Most studies of the interplay effect have been based on 4D CT scans and do not include irregular breathing. In contrast, this study use real 3D organ motions recorded during actual treatments. We establish a method to calculate the dose delivered to moving targets in scanning proton therapy by a commercial treatment planning system (TPS), and apply this method to investigate interplay effects for a number of liver SBRT patients with known tumor motion. Materials and Methods: Two three-field scanning proton plans (IMPT and single-field-optimization (SFO)) with 4mm spot spacing and a mean GTV dose of 18.75Gy per fraction were created for sixteen patients who were previously treated with three-fraction x-ray SBRT on a linear
